Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes

References

• Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–65.
   PubMed Web of Science ®Google Scholar
• Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Cardiovasc Diabetol. 2018;17(1):1. doi:10.1186/s12933-017-0656-x
   PubMedGoogle Scholar
• Wolf A, Zalpour C, Theilmeier G, et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol. 1997;29(3):479–485. doi:10.1016/S0735-1097(97)00523-8
   PubMed Web of Science ®Google Scholar
• Nakayama M, Yasue H, Yoshimura M, et al. T-786–>C mutation in the 5ʹ-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99(22):2864–2870. PMID: 10359729. doi:10.1161/01.cir.99.22.2864
   PubMed Web of Science ®Google Scholar
• Eröz R, Bahadir A, Dikici S, Tasdemir S. Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, −786T/C, G10T) and clinical findings in patients with migraine. Neuromolecular Med. 2014;16(3):587–593. PMID: 24845269. doi:10.1007/s12017-014-8311-0
   PubMed Web of Science ®Google Scholar
• Safarinejad MR, Khoshdel A, Shekarchi B, Taghva A, Safarinejad S. Association of the T-786C, G894T and 4a/4b polymorphisms of the endothelial nitric oxide synthase gene with vasculogenic erectile dysfunction in Iranian subjects. BJU Int. 2011;107(12):1994–2001. PMID: 20955262. doi:10.1111/j.1464-410X.2010.09755.x
   PubMed Web of Science ®Google Scholar
• Joshi MS, Ferguson TB Jr, Johnson FK, Johnson RA, Parthasarathy S, Lancaster JR Jr. Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells. Proc Natl Acad Sci USA. 2007;104(24):9982–9987. PMID: 17535904; PMCID: PMC1891228. doi:10.1073/pnas.0506824104
   PubMed Web of Science ®Google Scholar
• Liu H, Li J, Zhao F, Wang H, Qu Y, Mu D. Nitric oxide synthase in hypoxic or ischemic brain injury. Rev Neurosci. 2015;26(1):105–117. PMID: 25720056. doi:10.1515/revneuro-2014-0041
   PubMed Web of Science ®Google Scholar
• Pereira TV, Rudnicki M, Cheung BM, et al. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens. 2007;25(9):1763–1774. PMID: 17762636. doi:10.1097/HJH.0b013e3281de740d
   PubMed Web of Science ®Google Scholar
• Lee YC, Huang SP, Liu CC, et al. The association of eNOS G894T polymorphism with metabolic syndrome and erectile dysfunction. J Sex Med. 2012;9(3):837–843. PMID: 22304542. doi:10.1111/j.1743-6109.2011.02588.x
   PubMed Web of Science ®Google Scholar
• Tain YL, Hsu CN. Toxic dimethylarginines: asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Toxins. 2017;9(3):92. doi:10.3390/toxins9030092
   PubMed Web of Science ®Google Scholar
• Dowsett L, Higgins E, Alanazi S, Alshuwayer NA, Leiper FC, Leiper J. ADMA: a key player in the relationship between vascular dysfunction and inflammation in atherosclerosis. J Clin Med. 2020;9(9):3026. doi:10.3390/jcm9093026
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-A meta-analysis. Nephrol Dial Transplant. 2006;21(9):2446–2451. doi:10.1093/ndt/gfl292
   PubMed Web of Science ®Google Scholar
• Li D, Guo R, Chen QQ, Hu CP, Chen X. Increased plasma level of asymmetric dimethylarginine in hypertensive rats facilitates platelet aggregation: role of plasma tissue factor. Can J Physiol Pharmacol. 2011;89(3):151–158. doi:10.1139/Y10-115
   PubMed Web of Science ®Google Scholar
• Brunini TMC, Moss MB, Siqueira MAS, et al. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and NG-monomethyl-l-arginine: effects of arterial hypertension. Clin Exp Pharmacol Physiol. 2004;31(10):738–740. doi:10.1111/j.1440-1681.2004.04067.x
   PubMed Web of Science ®Google Scholar
• Gawrys J, Gajecki D, Szahidewicz-Krupska E, Doroszko A, Stanek A. Intraplatelet L-arginine-nitric oxide metabolic pathway: from discovery to clinical implications in prevention and treatment of cardiovascular disorders. Oxid Med Cell Longev. 2020;2020:1–11. doi:10.1155/2020/1015908
   Web of Science ®Google Scholar
• Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88(5):1559–1567. doi:10.1172/JCI115467
   PubMed Web of Science ®Google Scholar
• Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83(3):1057–1062. doi:10.1161/01.CIR.83.3.1057
   PubMed Web of Science ®Google Scholar
• Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86(1):228–234. doi:10.1172/JCI114688
   PubMed Web of Science ®Google Scholar
• Jin L, Abou-Mohamed G, Caldwell RB, Caldwell RW. Endothelial cell dysfunction in a model of oxidative stress. Med Sci Monit. 2001;7(4):585–591.
   PubMedGoogle Scholar
• Mayhan WG, Patel KP, Sharpe GM. Effect of arginine on reactivity of hamster cheek pouch arterioles during diabetes mellitus. Int J Microcirc Exp. 1997;17(3):107–112. doi:10.1159/000179217
   PubMedGoogle Scholar
• Rector TS, Bank AJ, Mullen KA, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation. 1996;93(12):2135–2141. doi:10.1161/01.CIR.93.12.2135
   PubMed Web of Science ®Google Scholar
• Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;86(1):279–288. doi:10.1161/01.CIR.86.1.279
   PubMed Web of Science ®Google Scholar
• Li XK, Bin LQ, Chen WW, et al. Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Sci Transl Med. 2018;10(459):eaat4162. doi:10.1126/scitranslmed.aat4162
   PubMed Web of Science ®Google Scholar
• Gasecka A, Nieuwland R, Budnik M, et al. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction. Platelets. 2020;31(1):26–32. doi:10.1080/09537104.2018.1557616
   PubMed Web of Science ®Google Scholar
• Uk CB, Germany GH, Germany AK, Lenzen MJ, Denmark EP, Vranckx P. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST -segment elevation The Task Force for the management of acute myocardial infarction. Eur Heart J. 2017;2017:1–66.
   Google Scholar
• Valgimigli M, Germany UL, Germany JM. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation – web addenda task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment; 2015.
   Google Scholar
• Gasecka A, Nieuwland R, van der Pol E, et al. P2y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. Cardiol J. 2019;26(6):782–789. doi:10.5603/CJ.a2018.0045
   PubMed Web of Science ®Google Scholar
• Cavalca V, Veglia F, Squellerio I, et al. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-st-elevation myocardial infarction. PLoS One. 2012;7(11):1–8. doi:10.1371/journal.pone.0048499
   Web of Science ®Google Scholar
• Djordjević BV, Pavlović R, Ćosić V, et al. YHigh clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease. Amino Acids. 2012;43(6):2293–2300. doi:10.1007/s00726-012-1307-x
   PubMed Web of Science ®Google Scholar
• Krzystek-Korpacka M, Wiśniewski J, Fleszar MG, et al. Metabolites of the Nitric oxide (NO) pathway are altered and indicative of reduced NO and arginine bioavailability in patients with cardiometabolic diseases complicated with chronic wounds of lower extremities: targeted metabolomics approach (LC-MS/MS). Oxid Med Cell Longev. 2019;2019:1–13. doi:10.1155/2019/5965721
   Web of Science ®Google Scholar
• Goonasekera CDA, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens. 1997;15(8):901–909. doi:10.1097/00004872-199715080-00015
   PubMed Web of Science ®Google Scholar
• Boger RH, Bode-Boger SM, Thiele W, et al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997;95(8):2068–2074.
   PubMed Web of Science ®Google Scholar
• Boger RH, Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98(18):1842–1847. doi:10.1161/01.CIR.98.18.1842
   PubMed Web of Science ®Google Scholar
• Pettersson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand. 1998;77(8):808–813. doi:10.1080/j.1600-0412.1998.770805.x
   PubMed Web of Science ®Google Scholar
• Yoo JH, Lee SC. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis. 2001;158(2):425–430. doi:10.1016/S0021-9150(01)00444-0
   PubMed Web of Science ®Google Scholar
• Fard A, Tuck CH, Donis JA, et al. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2000;20(9):2039–2044. doi:10.1161/01.ATV.20.9.2039
   PubMed Web of Science ®Google Scholar
• Gore MO, Lüneburg N, Schwedhelm E, et al. Symmetrical dimethylarginine predicts mortality in the general population: observations from the dallas heart study. Arterioscler Thromb Vasc Biol. 2013;33(11):2682–2688. doi:10.1161/ATVBAHA.113.301219
   PubMed Web of Science ®Google Scholar
• Schulze F, Carter AM, Schwedhelm E, et al. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis. 2010;208(2):518–523. doi:10.1016/j.atherosclerosis.2009.06.039
   PubMed Web of Science ®Google Scholar
• Zeller M, Korandji C, Guilland JC, et al. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2008;28(5):954–960. PMID: 18276906. doi:10.1161/ATVBAHA.108.162768
   PubMed Web of Science ®Google Scholar
• Sen N, Ozlu MF, Akgul EO, et al. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. Atherosclerosis. 2011;219(1):304–310. PMID: 21726864. doi:10.1016/j.atherosclerosis.2011.06.021
   PubMed Web of Science ®Google Scholar
• Cavusoglu E, Ruwende C, Chopra V, et al. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography. Coron Artery Dis. 2009;20(2):112–117. doi:10.1097/MCA.0b013e328323982f
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Wang Z, Koeth R, et al. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation. 2007;116(20):2315–2324. PMID: 17967979. doi:10.1161/CIRCULATIONAHA.107.693986
   PubMed Web of Science ®Google Scholar
• Schepers E, Glorieux G, Dhondt A, Leybaert L, Vanholder R. Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant. 2009;24(5):1429–1435. doi:10.1093/ndt/gfn670
   PubMed Web of Science ®Google Scholar
• Lüneburg N, Harbaum L, Hennigs JK. The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases. Biomed Res Int. 2014;2014:1–11. doi:10.1155/2014/501612
   Web of Science ®Google Scholar
• Li J, Zhang Y, Li C, et al. HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism. Cardiovasc Res. 2013;99(4):674–684. PMID: 23729663. doi:10.1093/cvr/cvt139
   PubMed Web of Science ®Google Scholar
• Chen LL, Yin H, Huang J. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis. Cardiovasc Pathol. 2007;16(4):221–230. PMID: 17637430. doi:10.1016/j.carpath.2007.02.007
   PubMed Web of Science ®Google Scholar
• Kim MH, Choi SY, An SY, Serebruany V. Validation of three platelet function tests for bleeding risk stratification during dual antiplatelet therapy following coronary interventions. Clin Cardiol. 2016;39(7):385–390. doi:10.1002/clc.22540
   PubMed Web of Science ®Google Scholar
• Gasecka A, Böing AN, Filipiak KJ, Nieuwland R. Platelet extracellular vesicles as biomarkers for arterial thrombosis. Platelets. 2017;28(3):228–234. doi:10.1080/09537104.2016.1254174
   PubMed Web of Science ®Google Scholar